Zeynep Vardar

Radiology
14551 Hope Center Loop Ste 100
Fort Myers, FL 33912

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial.

Journal: The New England journal of medicine
Published: February 10, 2026

AAV9 Gene Therapy in GM1 Gangliosidosis Type II: A Phase 1/2 Trial.

AAV9 Gene Therapy in GM1 Gangliosidosis Type II: A Phase 1/2 Trial.

Journal: medRxiv : the preprint server for health sciences
Published: August 06, 2025

Corrigendum to "Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients" [Molecular Genetics and Metabolism 2025 Mar;144(3):109025].

Corrigendum to "Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients" [Molecular Genetics and Metabolism 2025 Mar;144(3):109025].

Journal: Molecular genetics and metabolism
Published: April 17, 2025

A Case for Automated Segmentation of MRI Data in Milder Neurodegenerative Diseases.

A Case for Automated Segmentation of MRI Data in Milder Neurodegenerative Diseases.

Journal: medRxiv : the preprint server for health sciences
Published: March 04, 2025

A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis.

A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis.

Journal: NeuroSci
Published: February 20, 2025

Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial.

Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial.

Journal: Nature medicine
Published: December 20, 2024

Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients.

Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients.

Journal: Molecular genetics and metabolism
Published: December 01, 2024

Differential Tractography: A Biomarker for Neuronal Function in Neurodegenerative Disease.

Differential Tractography: A Biomarker for Neuronal Function in Neurodegenerative Disease.

Journal: medRxiv : the preprint server for health sciences
Published: October 07, 2024

Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases.

Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases.

Journal: Human gene therapy
Published: September 26, 2024

Differential tractography: an imaging marker for tissue degeneration in neurodegenerative diseases.

Differential tractography: an imaging marker for tissue degeneration in neurodegenerative diseases.

Journal: Brain communications
Published: September 11, 2024

Quantitative reliability assessment of brain MRI volumetric measurements in type II GM1 gangliosidosis patients.

Quantitative reliability assessment of brain MRI volumetric measurements in type II GM1 gangliosidosis patients.

Journal: Frontiers in neuroimaging
Published: April 01, 2024

A novel intrasaccular aneurysm device with high complete occlusion rate: initial results in a rabbit model.

A novel intrasaccular aneurysm device with high complete occlusion rate: initial results in a rabbit model.

Journal: Journal of neurointerventional surgery
Published: May 03, 2023
Showing 1-12 of 22

Last Updated: 09/26/2026